PubMed:15814824 / 1719-1847 JSONTXT

{"project":"uniprot-human","denotations":[{"id":"T21","span":{"begin":108,"end":111},"obj":"http://www.uniprot.org/uniprot/Q99075"}],"text":"In contrast, the IgG response in patients with adenocarcinoma shifted to higher frequencies of preferential DTR peptide binding."}

{"project":"GO-MF","denotations":[{"id":"T2","span":{"begin":120,"end":127},"obj":"http://purl.obolibrary.org/obo/GO_0070026"},{"id":"T3","span":{"begin":120,"end":127},"obj":"http://purl.obolibrary.org/obo/GO_0003680"},{"id":"T4","span":{"begin":120,"end":127},"obj":"http://purl.obolibrary.org/obo/GO_0017091"},{"id":"T5","span":{"begin":120,"end":127},"obj":"http://purl.obolibrary.org/obo/GO_0005488"}],"text":"In contrast, the IgG response in patients with adenocarcinoma shifted to higher frequencies of preferential DTR peptide binding."}

{"project":"EDAM-topics","denotations":[{"id":"T20","span":{"begin":112,"end":119},"obj":"http://edamontology.org/topic_0154"}],"text":"In contrast, the IgG response in patients with adenocarcinoma shifted to higher frequencies of preferential DTR peptide binding."}

{"project":"EDAM-DFO","denotations":[{"id":"T18","span":{"begin":112,"end":119},"obj":"http://edamontology.org/data_2906"}],"text":"In contrast, the IgG response in patients with adenocarcinoma shifted to higher frequencies of preferential DTR peptide binding."}

{"project":"DisGeNET5_gene_disease","denotations":[{"id":"15814824-9#108#111#gene1839","span":{"begin":108,"end":111},"obj":"gene1839"},{"id":"15814824-9#108#111#gene286187","span":{"begin":108,"end":111},"obj":"gene286187"},{"id":"15814824-9#47#61#diseaseC0001418","span":{"begin":47,"end":61},"obj":"diseaseC0001418"}],"relations":[{"id":"108#111#gene183947#61#diseaseC0001418","pred":"associated_with","subj":"15814824-9#108#111#gene1839","obj":"15814824-9#47#61#diseaseC0001418"},{"id":"108#111#gene28618747#61#diseaseC0001418","pred":"associated_with","subj":"15814824-9#108#111#gene286187","obj":"15814824-9#47#61#diseaseC0001418"}],"text":"In contrast, the IgG response in patients with adenocarcinoma shifted to higher frequencies of preferential DTR peptide binding."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T10","span":{"begin":0,"end":128},"obj":"Sentence"},{"id":"T10","span":{"begin":0,"end":128},"obj":"Sentence"},{"id":"T10","span":{"begin":0,"end":128},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In contrast, the IgG response in patients with adenocarcinoma shifted to higher frequencies of preferential DTR peptide binding."}

{"project":"DisGeNET","denotations":[{"id":"T8","span":{"begin":108,"end":111},"obj":"gene:286187"},{"id":"T9","span":{"begin":47,"end":61},"obj":"disease:C0001418"},{"id":"T10","span":{"begin":108,"end":111},"obj":"gene:1839"},{"id":"T11","span":{"begin":47,"end":61},"obj":"disease:C0001418"}],"relations":[{"id":"R5","pred":"associated_with","subj":"T8","obj":"T9"},{"id":"R6","pred":"associated_with","subj":"T10","obj":"T11"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"In contrast, the IgG response in patients with adenocarcinoma shifted to higher frequencies of preferential DTR peptide binding."}

{"project":"mondo_disease","denotations":[{"id":"T3","span":{"begin":47,"end":61},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0004970"}],"text":"In contrast, the IgG response in patients with adenocarcinoma shifted to higher frequencies of preferential DTR peptide binding."}

{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T3","span":{"begin":47,"end":61},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0004970"}],"text":"In contrast, the IgG response in patients with adenocarcinoma shifted to higher frequencies of preferential DTR peptide binding."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T10","span":{"begin":0,"end":128},"obj":"Sentence"},{"id":"T10","span":{"begin":0,"end":128},"obj":"Sentence"},{"id":"T10","span":{"begin":0,"end":128},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In contrast, the IgG response in patients with adenocarcinoma shifted to higher frequencies of preferential DTR peptide binding."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T10","span":{"begin":0,"end":128},"obj":"Sentence"}],"text":"In contrast, the IgG response in patients with adenocarcinoma shifted to higher frequencies of preferential DTR peptide binding."}